Parikh Asit (CIK 1796787) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-21). Recent activity: Buy PHAT (24,122 shares), Buy PHAT (17,500 shares), Sell PHAT (40,000 shares), Buy PHAT (40,000 shares), Sell PHAT (80,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Buy | 24,122 | $0 |
| 2026-05-21 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Buy | 17,500 | $86,625 |
| 2026-03-11 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Sell | 40,000 | $0 |
| 2026-03-11 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Buy | 40,000 | $0 |
| 2026-01-27 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Sell | 80,500 | $0 |
| 2026-01-27 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Buy | 80,500 | $0 |
| 2026-01-15 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Buy | 8,750 | $90,125 |
| 2025-12-23 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Buy | 8,750 | $90,125 |
| 2025-06-05 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Buy | 10,500 | $0 |
| 2025-05-08 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Buy | 5,000 | $13,000 |
| 2025-05-08 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Buy | 5,000 | $12,000 |
| 2025-03-21 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Buy | 7,500 | $87,900 |
| 2025-03-17 | Phathom Pharmaceuticals, Inc. (PHAT) | Director | Buy | 10,000 | $44,200 |
Source: SEC Form 4 filings · as of 2026-05-21